These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8594306)

  • 1. Sex and age differences in soluble guanylate cyclase activity in human platelets.
    Michimata T; Imamura M; Mizuma H; Murakami M; Iriuchijima T
    Life Sci; 1996; 58(5):415-9. PubMed ID: 8594306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
    Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
    Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
    Gerzer R; Karrenbrock B; Siess W; Heim JM
    Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
    Severina IS
    Adv Enzyme Regul; 1992; 32():35-56. PubMed ID: 1353937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guanylate cyclase from human blood platelets].
    Chirkov IuIu; Tyshchuk IA; Belushkina NN; Severina IS
    Biokhimiia; 1987 Jun; 52(6):956-63. PubMed ID: 2889477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carnosine on the activation of human platelet soluble guanylate cyclase by sodium nitroprusside and protoporphyrin IX.
    Severina IS; Busygina OG
    Biochem Int; 1990 Nov; 22(3):455-65. PubMed ID: 1981669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human thrombocyte guanylate cyclase in diabetes mellitus].
    Chirkov IuIu; Tyshchuk IA; Severina IS; Starosel'tseva LK
    Biull Eksp Biol Med; 1989 Mar; 107(3):300-2. PubMed ID: 2565738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of guanylate cyclase and the regulatory role of cyclic 3',5'-guanosine monophosphate.
    Severina IS
    Biochem Int; 1988 Aug; 17(2):265-78. PubMed ID: 2903739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS
    Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in activating ability of human platelet guanylate cyclase during aggregation.
    Severina IS; Belushkina NN
    Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
    Gambaryan S; Subramanian H; Rukoyatkina N; Herterich S; Walter U
    Thromb Haemost; 2013 May; 109(5):973-5. PubMed ID: 23467662
    [No Abstract]   [Full Text] [Related]  

  • 13. [An endogenous regulator of the guanylate cyclase activity of human platelets].
    Busygina OG; Severina IS
    Biokhimiia; 1990 Oct; 55(10):1812-8. PubMed ID: 1981850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conditions of activation of guanylate cyclase from human platelets].
    Chirkov IuIu; Tyshchuk IA; Severina IS
    Biokhimiia; 1988 Sep; 53(9):1520-6. PubMed ID: 2904828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase.
    Severina IS; Bussygina OG; Pyatakova NV; Khropov YV; Krasnoperov RA
    Eur J Pharmacol; 2000 Oct; 407(1-2):61-4. PubMed ID: 11050291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible activation of soluble guanylate cyclase by oxidizing agents.
    Wu XB; Brüne B; von Appen F; Ullrich V
    Arch Biochem Biophys; 1992 Apr; 294(1):75-82. PubMed ID: 1347985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B; Grewe R; Loeschke K; Gerzer R
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets.
    Medvedev A; Bussygyna O; Pyatakova N; Glover V; Severina I
    Biochem Pharmacol; 2002 Feb; 63(4):763-6. PubMed ID: 11992646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylate cyclase in human platelets with different aggregability.
    Chirkov YuYu ; Tyshchuk IA; Severina IS
    Experientia; 1990 Jul; 46(7):697-9. PubMed ID: 1973657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guanylate cyclase from human platelets in pulmonary tuberculosis].
    Riaposova IK; Ioshina EG; Severina IS
    Vopr Med Khim; 1990; 36(5):21-4. PubMed ID: 1979193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.